Literature DB >> 18625685

Host-pathogen interactions in Campylobacter infections: the host perspective.

Riny Janssen1, Karen A Krogfelt, Shaun A Cawthraw, Wilfrid van Pelt, Jaap A Wagenaar, Robert J Owen.   

Abstract

Campylobacter is a major cause of acute bacterial diarrhea in humans worldwide. This study was aimed at summarizing the current understanding of host mechanisms involved in the defense against Campylobacter by evaluating data available from three sources: (i) epidemiological observations, (ii) observations of patients, and (iii) experimental observations including observations of animal models and human volunteer studies. Analysis of available data clearly indicates that an effective immune system is crucial for the host defense against Campylobacter infection. Innate, cell-mediated, and humoral immune responses are induced during Campylobacter infection, but the relative importance of these mechanisms in conferring protective immunity against reinfection is unclear. Frequent exposure to Campylobacter does lead to the induction of short-term protection against disease but most probably not against colonization. Recent progress in the development of more suitable animal models for studying Campylobacter infection has opened up possibilities to study the importance of innate and adaptive immunity during infection and in protection against reinfection. In addition, advances in genomics and proteomics technologies will enable more detailed molecular studies. Such studies combined with better integration of host and pathogen research driven by epidemiological findings may truly advance our understanding of Campylobacter infection in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625685      PMCID: PMC2493085          DOI: 10.1128/CMR.00055-07

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  171 in total

Review 1.  Animal models of Campylobacter jejuni colonization and disease and the lessons to be learned from similar Helicobacter pylori models.

Authors:  D G Newell
Journal:  Symp Ser Soc Appl Microbiol       Date:  2001

Review 2.  Outbreaks of waterborne infectious intestinal disease in England and Wales, 1992-2003.

Authors:  A Smith; M Reacher; W Smerdon; G K Adak; G Nichols; R M Chalmers
Journal:  Epidemiol Infect       Date:  2006-05-11       Impact factor: 2.451

3.  Spatial distribution and registry-based case-control analysis of Campylobacter infections in Denmark, 1991-2001.

Authors:  Steen Ethelberg; Jacob Simonsen; Peter Gerner-Smidt; Katharina E P Olsen; Kåre Mølbak
Journal:  Am J Epidemiol       Date:  2005-10-05       Impact factor: 4.897

Review 4.  The immunobiology of Guillain-Barré syndromes.

Authors:  Hugh J Willison
Journal:  J Peripher Nerv Syst       Date:  2005-06       Impact factor: 3.494

5.  Activation of toll-like receptor 9 by DNA from different bacterial species.

Authors:  Alexander Dalpke; Jutta Frank; Mirjam Peter; Klaus Heeg
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

6.  Campylobacter jejuni induces secretion of proinflammatory chemokines from human intestinal epithelial cells.

Authors:  Lan Hu; Thomas E Hickey
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

7.  Clinical and serological manifestations in patients during a waterborne epidemic due to Campylobacter jejuni.

Authors:  K Melby; O P Dahl; L Crisp; J L Penner
Journal:  J Infect       Date:  1990-11       Impact factor: 6.072

8.  Murine intranasal challenge model for the study of Campylobacter pathogenesis and immunity.

Authors:  S Baqar; A L Bourgeois; L A Applebee; A S Mourad; M T Kleinosky; Z Mohran; J R Murphy
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

9.  Apolipoprotein E genotypes and clinical outcome in Guillain-Barré syndrome.

Authors:  J Pritchard; R A C Hughes; J H Rees; H J Willison; J A R Nicoll
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

10.  Interleukin-10 promoter polymorphisms in patients with Guillain-Barré syndrome.

Authors:  K-M Myhr; K S Vågnes; T H Marøy; J H Aarseth; H I Nyland; C A Vedeler
Journal:  J Neuroimmunol       Date:  2003-06       Impact factor: 3.478

View more
  98 in total

Review 1.  The role of probiotics in the inhibition of Campylobacter jejuni colonization and virulence attenuation.

Authors:  V Mohan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-02       Impact factor: 3.267

2.  Virulence genes and cytokine profile in systemic murine Campylobacter coli infection.

Authors:  Anja Klančnik; Maja Šikić Pogačar; Peter Raspor; Maja Abram; Sonja Smole Možina; Darinka Vučković
Journal:  Virulence       Date:  2015-06-03       Impact factor: 5.882

Review 3.  A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.

Authors:  Alexander C Maue; Frédéric Poly; Patricia Guerry
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

4.  Mucosal reactive oxygen species decrease virulence by disrupting Campylobacter jejuni phosphotyrosine signaling.

Authors:  Nicolae Corcionivoschi; Luis A J Alvarez; Thomas H Sharp; Monika Strengert; Abofu Alemka; Judith Mantell; Paul Verkade; Ulla G Knaus; Billy Bourke
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

5.  Simultaneous glycan-peptide characterization using hydrophilic interaction chromatography and parallel fragmentation by CID, higher energy collisional dissociation, and electron transfer dissociation MS applied to the N-linked glycoproteome of Campylobacter jejuni.

Authors:  Nichollas E Scott; Benjamin L Parker; Angela M Connolly; Jana Paulech; Alistair V G Edwards; Ben Crossett; Linda Falconer; Daniel Kolarich; Steven P Djordjevic; Peter Højrup; Nicolle H Packer; Martin R Larsen; Stuart J Cordwell
Journal:  Mol Cell Proteomics       Date:  2010-04-01       Impact factor: 5.911

6.  Genotyping of Campylobacter jejuni Isolates from Poultry by Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR).

Authors:  Hung-Yueh Yeh; Amal Awad
Journal:  Curr Microbiol       Date:  2020-04-11       Impact factor: 2.188

Review 7.  Human Campylobacteriosis-A Serious Infectious Threat in a One Health Perspective.

Authors:  Markus M Heimesaat; Steffen Backert; Thomas Alter; Stefan Bereswill
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

8.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

9.  Campylobacter jejuni colonization in wild birds: results from an infection experiment.

Authors:  Jonas Waldenström; Diana Axelsson-Olsson; Björn Olsen; Dennis Hasselquist; Petra Griekspoor; Lena Jansson; Susann Teneberg; Lovisa Svensson; Patrik Ellström
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

10.  Campylobacter jejuni outer membrane vesicles play an important role in bacterial interactions with human intestinal epithelial cells.

Authors:  Abdi Elmi; Eleanor Watson; Pamela Sandu; Ozan Gundogdu; Dominic C Mills; Neil F Inglis; Erin Manson; Lisa Imrie; Mona Bajaj-Elliott; Brendan W Wren; David G E Smith; Nick Dorrell
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.